Palantir Wins FDA Contract to Power Drug Review, Inspections

Published December 7, 2020

Palantir Technologies Inc. won a deal with the U.S. Food and Drug Administration (FDA) to help power drug reviews and inspections, further expanding the company’s government business as it hustles to hit a raised revenue target for 2020.